Analysis of primary DLBCL samples revealed positive nuclear co-staining for the oncogene product IRF2, STAT1-pY701 and STAT1-pS727 in 18 % of the primary DLBCL tumor samples analyzed, while benign tissue did not show this pattern in any case [470]. The gene discussed is STAT1; the disease is diffuse large B-cell lymphoma.